widely used in animal models to study AKI. Evidence shows that kidney injury and cell death can be caused during ischemic stress with depletion of ATP, activation of enzymes including phospholipases, proteases, and reactive oxygen species (ROS), generating enzymes like nitric oxide synthase that occur as early as 2 h after IR (8, 15, 18) . Since the kidney is the major organ for excreting metabolic end products, its injury can cause changes in the renal metabolic profile, and understanding its influence on kidney function will shed light on new potential diagnostic markers and therapeutic targets in AKI (17, 21, 34, 43) . Advances in functional genomics and proteomics have fostered progress in our understanding of the pathogenic mechanisms involved and identified some novel protein biomarkers and candidate therapeutic targets in plasma, urine, and tissues which precede changes in commonly used clinical markers of renal dysfunction like plasma creatinine (6, 14, 18, 29, 41) . Comparatively little, however, is known regarding the role of lipids in pathogenic mechanisms of AKI (1, 5, 39) .
Major lipids like glycerophospholipids and sphingolipids have an important role in membrane bilayer structure, energy storage, and cell signaling and provide functional support to membrane proteins (36) . Prior studies have shown that various forms of AKI, including IR, induce cellular membrane instability, causing lipid dysfunction and abnormal lipid accumulation within the kidney, which may be either protective or toxic to the kidney depending on the nature of the lipid species and the time course of the injury (13, 25, 46) . For example, ether-linked phosphatidylcholines (PC) and phosphatidylethanolamines (PE) have been implicated in a range of developmental and pathogenic processes related to tissue injury, where they are enriched in proximal tubules of the kidney and can modulate membrane turnover, as well as protect against oxidative stress by reducing sensitivity to ROS in the case of plasmalogens that are characterized by the presence of a vinyl ether linkage of the sn1 alkyl chain (3, 10) . Ether lipids can also be hydrolyzed by phospholipase A 2 (PLA 2 ) enzymes during ischemic injury, leading to the accumulation of fatty acid precursors of inflammatory oxylipids that may lead to irreversible cell injury within an hour of the insult (3, 24) . Lipid oxidation has also been negatively correlated with IRinduced AKI (16) . Thus there is a need to apply experimental approaches capable not only of identifying changes in a broad range of lipids within the renal lipidome that correlate with the severity of AKI but also of helping to determine whether these changes occur in areas of the kidney that are principally affected by AKI. In other words, both quantitative and spatial information on renal lipid changes are required to identify those lipid changes that are most likely to be pathophysiologically relevant and/or of greatest potential biomarker utility.
Although targeted mass spectrometry (MS) approaches have been used to identify new lipids which may have causative roles in AKI (31, 47) , the significance of those lipids identified is often not clear. Furthermore, targeted MS approaches suffer from underrepresentation of major lipid classes within any single MS assay, necessitating the use of many independent MS approaches to obtain a picture of renal lipid changes. To overcome this limitation, we utilized an untargeted sequential window acquisition of all theoretical spectra (SWATH)-MS method (35) to identify novel lipid changes early following IR-induced kidney injury and select for those that correlated with AKI severity. This data-independent acquisition MS method combines the advantages of high throughput shotgun lipidomics with the high reproducibility of selected reactionmonitoring MS approaches. Using matrix-assisted laser desorption ionization imaging mass spectrometry (MALDI-IMS), we then sought to localize those lipids that changed in the kidney in proportion to AKI severity early after IR to specific renal structures known to be affected by IR to further assess their potential significance.
MATERIALS AND METHODS
Animals. Male C57BL/6 mice (10 -12 wk old) were used for experiments. Animals were fed a standard diet and allowed free access to water. The Institutional Animal Care and Use Committee of the University of Alabama at Birmingham approved all the animal work.
Renal IR surgery. For anesthetization, mice (n ϭ 6) were induced using 2.5% isoflurane by inhalation and then maintained with 1.5% isoflurane by inhalation during sham or IR surgery. Under aseptic precautions, a right nephrectomy was performed via a right flank incision. A similar incision was made in the left flank, and the left renal pedicle was exposed, secured, and clamped with a microserrefine atraumatic vascular clamp (18055-05, Fine Science Tools, Foster City, CA) for 30 min. Blanching of the entire kidney ensured loss of blood flow. During this period, the kidney was kept moist, using sterile gauze soaked in saline. At the end of ischemia, the clamp was removed to allow reperfusion, which was confirmed visually, and the kidney was returned to the abdominal cavity in its original position. An additional group of animals (n ϭ 6) underwent sham surgery in which a right nephrectomy was performed and the left renal pedicle was exposed, but was not clamped. Mice were euthanized with a lethal dose of pentobarbital sodium (0.4 ml, 50 mg/kg), and blood was collected for creatinine levels, which was determined using liquid chromatography-tandem MS (LC-MS/MS) performed at the UAB-UCSD O'Brien Center Bioanalytical Core facility.
Tissue processing. One-half of each mouse kidney was weighed and homogenized in 500 l PBS-butylated hydroxytoluene (BHT; 2,6-Di-tert-butyl-4-methylphenol, B1378, Sigma) for 30 s followed by sonication for 10 s using a sonic dismembrator (FB-50, Fisher Scientific). Homogenates were stored under argon at Ϫ80°C until extraction. Tissue weight was normalized between animals, and lipids were extracted by the Bligh-Dyer method, dried down under argon, and stored at Ϫ80°C until MS analysis. The other half of the kidney was embedded in 10% gelatin blocks for MALDI-IMS as described below.
SWATH-MS. Lipid extracts were resuspended in 500 l 2:1 methanol:chloroform containing 5 mM ammonium acetate. Samples were infused into a 5600 Triple-TOF mass spectrometer (Sciex) by isocratic flow at 7 l/min using a 500-l Hamilton gas tight syringe. For syringe cleaning, before and in between samples, the direct infusion syringe was cleaned with multiple solvents. The solvent wash steps included two flushes with 100% methanol, two flushes with 100% acetonitrile, two flushes with 100% isopropyl alcohol, and two flushes with 100% direct infusion solvent. Calibration standards for direct infusion analyses were provided by Sciex. The APCI Positive Calibration Solution (4460131) and APCI Negative Calibration Solution Parameters for instrumentation, such as curtain gas, GS1, GS2, spray voltage, and temperature were 20.00, 15.00, 5,500.00 (positive ion mode)/4,500 (negative ion mode), and 400°C, respectively. This yielded fragmentation into product ions to assist in identification of specific lipid classes. Two technical replicates were performed per sample in positive ion mode. The acquired TOF MS and MS/MS data were processed with LipidView 1.2 software (Sciex, Concord, Ontario, Canada). TOF precursor scans were tethered to product ion TOF MS/MS scans for identification of lipids with a mass tolerance of 5 mDa and deisotoping of the spectra. A mass tolerance of 0.01 Da was used for product ion scans with smoothing of individual spectra. The signalto-noise threshold was set to 3 with a minimum intensity cut off of 10 counts to be accepted, and lipid search parameters were set to allow for up to 6 double bonds and lyso-species variants.
Hydroxyoctadecadienoic acid/hydroxyeicosatetraenoic acid measurement. For renal hydroxyoctadecadienoic acid/hydroxyeicosatetraenoic acid (HODE/HETE) measurement, animals were perfused through the left ventricle with 20 ml PBS containing 50 M BHT (Sigma-Aldrich, St. Louis, MO). The kidney was removed, weighed, and homogenized in 2 ml PBS/BHT. Homogenates were stored in 500-l aliquots under argon at Ϫ80°C before analysis. Lipids were extracted from 500-l homogenate aliquots and analyzed by LC-MS/MS exactly as described in Black et al. (2) using a Shimadzu prominence HPLC system and an AB/Sciex API-4000 Q TRAP mass spectrometer.
Tissue sectioning and matrix application for MALDI-IMS. Mouse kidneys were embedded in 10% gelatin (G1890, wt/vol, aqueous, Sigma-Aldrich), frozen in liquid nitrogen-cooled isopentane, and stored at Ϫ80°C until use. Coronal cryosections (14 M) were cut at Ϫ20°C and thaw-mounted onto indium tin oxide (ITO)-coated slides (CG-81IN-S115, Delta Technologies). A digital image of the slide with cryosections was then acquired at 2,600-dpi resolution against a black background using a Canon Lide 210 scanner. Alternating sections from each block were placed on conventional microscope slides for immunofluorescence staining. Matrix (2,5-dihydroxybenzoic acid; DHB; 149357-25G, SigmaAldrich) was applied to each slide via sublimation using a vacuum sublimation apparatus comprising an Edwards RV12 vacuum pump with pirani vacuum gauge and digital display (Edwards Vacuum) attached to a glass sublimation chamber (8023, Ace Glassware). The slide was affixed to the bottom of the condenser unit of the sublimation chamber using double-sided carbon conductive tape (77802, Electron Microscopy Sciences), and 300 mg of DHB was evenly distributed on the bottom of the chamber. The chamber was attached to the vacuum apparatus via a cold trap (Z120790, Sigma-Aldrich). The pressure was allowed to reach 0.05 Torr while a slurry of dry ice and ethanol in the cold trap was maintained. Ice water was kept between 5 and 10°C in the condenser unit of the sublimation chamber, which was placed on top of a heated sand bath kept at 140°C for 10 min. After returning to ambient temperature and pressure, the matrixcoated slides were removed from the chamber and subjected to MALDI-IMS.
MALDI-TOF imaging and MS/MS.
Slides with DHB-coated tissue sections were placed into an MTP Slide Adaptor II (Bruker Daltonics, Billerica, MA) and analyzed on an AutoFlex Speed MALDI-TOF/ TOF mass spectrometer (Bruker Daltonics). Positive ion images were obtained in reflector mode over the mass range m/z 60-1,600 using a spatial resolution of 20 M raster step size. The sample rate was 2.00 GS/s, and the detector gain was 16.3ϫ. Laser size 1_minimum was used, and laser intensity was kept at 100% with the global attenuator set to 30%. The frequency was 1,000 Hz with 100 laser shots added per spot. Calibration was performed using a mixture of the following lipids: LPC ( MALDI-TOF MS/MS fragment ion spectra were collected using a low-mass LIFT method in positive ion mode over the mass range m/z 40 -950. The sample rate was 1.00 GS/s, and the detector gain was 3.8ϫ. Laser size 4_large was used at a frequency of 200 Hz, and laser intensity was 77%. The method was calibrated using the peptide angiotensin II (8208241, Bruker). The PCIS window was set to 4 Da on either side of the parent ion. Three spectra were summed together per MS/MS run, with 500 laser shots collected per spectrum. The resulting MS/MS spectra were loaded into FlexAnalysis software (Bruker Daltonics) to subtract the baseline and label the peaks. MS/MS spectra were interpreted using LIPID MAPS to match precursor ion masses and interpret fragmentation patterns.
Immunofluorescence staining. For immunofluorescence staining, sections collected onto conventional microscope slides were fixed with acetone, blocked with blocking buffer (2% normal horse serum, 2% normal goat serum in PBS) for 1 h, followed by incubation with rat anti-PECAM1 and fluorescein-labeled Lotus tetragonolobus lectin (Vector Laboratories, CA) for 2 h at room temperature. Following washes with PBS, sections were incubated in secondary antibody conjugated to Alexa Fluor 555 for 30 min at room temperature. Following washes with PBS, slides were mounted using Vectashield Hard Set Mounting Medium with 4,6-diamidino-2-phenylindole (DAPI; Vector Laboratories).
Statistics. Statistical analysis was performed using SigmaStat (Systat Software, San Jose, CA). Student's t-test was used for single comparisons, and the Pearson product moment test was used for correlation analyses. For all statistical analyses, P Ͻ 0.05 was considered significant.
RESULTS
We reasoned that many lipids would be changed at 24 h post-IR as a result of the excessive injury and inflammation at this time point (12) and that most therefore may not play significant roles in the initial pathology of AKI. To address this, we chose an additional early time point assuming that fewer lipids would be changed with IR and those that increase are more likely to exhibit a causal relationship with AKI severity. Compared with sham mice, plasma creatinine levels in IR mice were significantly higher at 6 and 24 h after reperfusion (P Ͻ 0.001) (Fig. 1A) . Histological features of tubular necrosis, loss of brush borders and cast formation, were evident at 24 h (Fig. 1B) in the kidneys of animals undergoing IR, but not in the kidneys from animals undergoing sham surgery. Importantly, renal injury as assessed by these parameters was less severe at 6 h compared with 24 h.
Ether-linked phospholipids are increased early in IR-induced AKI. We performed SWATH-MS analysis on kidney homogenates from IR and sham mice at both the 6-and 24-h time points after surgery. Together with the accurate parent lipid mass, MS/MS analysis in positive and negative modes provided identification of the parent lipid and their acyl chain distribution, respectively. Although numerous lipids were detected in positive mode at both time points, only four were changed (all increases) to a statistically significant extent at 6 h after IR (of a total 938) ( Fig. 2A, left) . Interestingly, of these four lipids that were increased significantly at 6 h after IR, three were identified as ether-linked phospholipids (one an abundant PC: PC O-38:1, and two PEs: an abundant PE O-42:3 and a minor PE O-40:4) ( Fig. 2A) . SWATH-MS/MS analysis in positive mode and negative modes produced ions which allowed the phospholipid headgroup and acyl chain designations, respectively, to be made for the two abundant ether lipids as follows: PC O-38:1 (PC O-18:0, 20:1) and PE O-42:3 (PE O-20:1, 22:2) (Fig. 3, A and B) . PC O-38:1 is a plasmanyl choline (Fig. 3A) , while PE O-42:3 is a plasmalogen by virtue of the vinyl linkage of the 20:1 sn1 alkyl chain (Fig. 3B) .
A minor ganglioside (glycospgingolipids enriched in membrane lipid rafts with sialic acid residues linked to the sugar IR, ischemia-reperfusion; AKI, acute kidney injury; tandem mass spectrometry (MS/MS), m/z: parent ion m/z followed by fragment ion m/z used for lipid identification; intensity change, average lipid intensity sham¡average lipid intensity IR. Reductions are highlighted in bold. Note that all statistically significant changes in PEs 24 h post-IR were reductions. chain), GD2 32:2;2, was also increased with IR at 6 h, but not detected at 24 h in either sham or IR mice (Fig. 2) . As anticipated, many more lipids were changed to a statistically significant extent at 24 h after IR (36% of a total of 1,088) ( Fig.  2A, right) . All statistically significant lipid changes detected at 24 h post-IR are shown in Tables 1-5 . Interestingly, while the abundant PC O-38:1 remained elevated in IR kidneys at 24 h compared with the 24-h sham group, the low-abundance PE O-40:4 was present at comparably low levels in kidneys of both IR and sham mice at 24 h (Fig. 2, B and C) . PE O-42:3, on the other hand, was present at high levels but was decreased at 24 h compared with its sham control group (Fig. 2C) , even though this lipid was increased relative to its sham control group at 6 h post-IR (Fig. 2B) . Interestingly, all ether-linked PEs and PEs detected by SWATH-MS 24 h post-IR were reduced with AKI (Tables 1-3 ). A positive correlation was seen between kidney PC O-38:1 levels and AKI severity at 6 h as measured by plasma creatinine concentration (r ϭ 0.730, P Ͻ 0.0062). Similar positive associations were present for PE O-42:3 (r ϭ 0.717, P ϭ 0.0087) and PE O-40:4 (r ϭ 0.771, P ϭ 0.0023) (Fig. 4A) . However, the increase in renal GD2 43:2;2 levels at 6 h did not show a statistically significant association with plasma creatinine (r ϭ Ϫ0.532, P ϭ 0.0748). This suggests that early increases in ether phospholipids are directly related to the pathology of AKI in this IR model.
Table 3. Lysophosphatidylcholine (LPC), ether-linked LPC (LPC O), lysophosphatidylethanolamine (LPE), and ether-linked LPE (LPE O) species changed to a statistically significant extent 24 h post-IR-induced AKI
Early changes in renal lipids following IR occur independently of lipid oxidation. Ether lipids can be hydrolyzed by PLA 2 enzymes during ischemic injury, leading to the accumulation of unsaturated linoleic and arachidonic acids and their oxidized derivatives (HODE and HETE acids, respectively) (42), many of which exhibit inflammatory properties that may lead to irreversible cell injury (3, 16, 24) . We therefore measured levels of HODEs and HETEs, as well as their fatty acid precursors, in kidneys of sham and IR animals at 6 h. No statistically significant differences in major HODEs and HETEs or linoleic and arachidonic acids were detected (Fig.  4B) , suggesting that phospholipid hydrolysis and fatty acid oxidation are not responsible for the lipid changes observed.
Localization of ether lipid increases in IR to proximal tubules by MALDI tissue imaging. PC O-38:1 was the most abundant of the ether phospholipids increased early in AKI (6 h) (Fig. 2, A and B) and also the only one remaining elevated compared with sham controls at 24 h (Fig. 2, C and D) . To provide additional evidence for its significance in addition to its correlation with AKI severity (Fig. 4A) , we performed MALDI-IMS in positive mode to determine whether PC O-38:1 localized to specific renal structures commonly affected by IR (Fig. 5) . The spatial distribution of PC O-38:1 was largely restricted to the corticomedullary area of the kidney, and immunofluorescence staining of adjacent tissue sections to those taken for MALDI imaging with L. tetragonolobus lectin (for proximal tubules) and anti-PECAM1 antibody (for endothelial cells) confirmed a distribution predominantly localized to proximal tubules rather than blood vessels (which is consistent with generation of the lipid in situ, as opposed to entry of the lipid from the circulation) (Fig. 5C) . Similarly to the positive mode SWATH-MS/MS analysis (Fig. 3A) , MALDI-MS/MS in positive mode on the corticomedullary area of sham and IR kidney cryosections gave the 184.1-m/z phosphocholine headgroup fragment ion expected for the PC O-38:1 sodium adduct (Fig. 5D ).
DISCUSSION
In this study, we used SWATH-MS to demonstrate that 6 h after renal IR in mice, the relative abundance of a small number of ether-linked phospholipids is significantly increased in the kidney compared with control animals (Fig. 2) independently of major changes in lipid oxidation (Fig. 4B) . Importantly, renal levels of these ether phospholipids correlated with plasma creatinine as a marker of AKI severity (Fig. 4A) . This suggests that they might play a causal or protective role in AKI and/or may prove to be effective early biomarkers for AKI. With respect to the latter possibility, it will be important to develop more sensitive targeted LC-MS/MS methods to determine whether any of the lipid changes we found are manifested in urine.
Lipid MALDI-IMS in combination with immunofluorescence staining of adjacent kidney cryosections revealed a predominant localization of the most abundant ether lipid increased (PC O-38:1) to the proximal tubules of the kidney, where rate-limiting peroxisomal acyltransferase and synthase enzymes for ether lipid biosynthesis are located (10) (Fig. 5) . Indeed, this region of the kidney is particularly rich in peroxisomes and is also known to be more prone to developing ischemia-related injury (19, 26, 44) . Thus spatially restricted ether lipid production in the proximal tubules of the kidney Reductions are highlighted in bold.
may play important roles early in AKI. However, some glomerular PC O-38:1 may also be present that could be detected using greater spatial resolution for MALDI-IMS than the 20 m used in this study. Ether-linked PC and PE species differ from the more common diacyl PCs and PEs in their utilization of a fatty alcohol, as opposed to a fatty acid, at the sn1 position (ether vs. ester sn1 linkage) (20) . Elevated levels of ether lipids have been widely reported in cancer tissues, and the discovery of important biological activities of distinctive ether-like lipids such as platelet-activating factor (PAF) (9, 37) greatly stimulated interest in these lipids. Notably, deficiency of ether-linked phospholipids in general is associated with numerous peroxisomal disorders including Zellweger's, and impaired peroxisomal ether lipid synthesis has been linked to defects in membrane trafficking and increased apoptosis (10, 38) . Peroxisomal ether lipid synthesis has also been shown to be important for sustaining membrane phospholipid composition and cell viability (19) . Our finding of elevations in select ether-linked phospholipids early in IR-induced kidney injury and the putative localization of the most abundant (PC O-38:1) to proximal tubules therefore provides important new information on the specific types of ether-linked phospholipids that are involved in AKI. Twenty-four hours following AKI induction (a time point commonly used to study mechanisms of AKI in this model), there were considerably more lipid changes associated with AKI ( Fig. 2B and Tables 1-4 ), likely because of the greater number and complexity of cellular and molecular processes related to injury, inflammation, and tissue repair occurring at this later time. In addition, of the two abundant ether phospholipids increased at 6 h (PC O-38:1 and PE O-42:3), only PC O-38:1 was still elevated compared with control animals at 24 h, with the plasmalogen PE O-42:3 reduced at this later time point (Fig. 2) . Although plasmalogens and other ether phospholipids can be hydrolyzed by calcium-independent PLA 2 enzymes at early time points in renal injury, their rapid turnover can result in maintenance of high levels which may be required to preserve normal membrane function and to confer protective antioxidant effects that prevent irreversible cell injury (28, 30) . This property may be of particular importance in AKI, where the accumulation of myeloperoxidase (MPO) activity derived from inflammatory leukocytes and ROS in the kidney can cause irreversible damage (27) . Indeed, "plasmalogen-deficient" mouse models succumb to oxidative stress, tissue injury, and peroxisomal dysfunction (10, 32, 33) . Sustained increases in renal PC O-38:1 levels up to 24 h following IR-induced AKI may therefore be significant in this respect, while the later reductions in the plasmalogen PE O-42:3 may reflect its "consumption" at later time points in IR due to abundant ROS generation and excessive damage to proximal tubules that are rich in the peroxisomal enzymes required for the synthesis of plasmalogens and other ether lipids (3). Indeed, all ether PEs detected 24 h post-IR were similarly reduced (Table 2) , strongly supporting this notion. This suggests that preventing ether PE reductions or restoring their levels (perhaps through modification of key enzymes) could provide some therapeutic benefit in AKI.
In conclusion, our study demonstrates that an untargeted SWATH-MS lipidomics approach in conjunction with MALDI imaging can be affordably used to provide quantitative and spatial information with which to narrow those changes in the renal lipidome associated with AKI to those lipids that have the greatest potential to be of pathophysiological significance by virtue of their correlation with AKI severity as well as their localization to renal sites known to be principally affected by AKI. Similarly, using a combination of quantitative and spatial MS approaches, Grove et al. (11) identified lipid changes associated with diabetic renal pathology. In addition to the use of different matrices for MALDI-IMS in this study, a separate MALDI Fourier transform ion cyclotron resonance MS system was used to obtain MS/MS spectra for diagnostic fragmentation analysis with improved mass resolution. Refinements to MALDI-IMS such as this, together with greater spatial resolution and the use of alternative matrices, will undoubtedly increase the number of candidate lipids that can be identified in this way and thus further our understanding of the molecular mechanisms in AKI. Determining whether those renal lipids identified early in AKI can be correlated with similar lipid changes in urine or plasma could also lay the foundation for the development of novel biomarkers for both diagnostic and prognostic benefits earlier in the course of AKI. 
